# Impact of Beta-lactams on the Microbiota and Relative Fecal Abundance of Mulltidrug Resistant Bacteria

> **NCT03338738** · NA · COMPLETED · sponsor: **Fondation Hôpital Saint-Joseph** · enrollment: 19 (actual)

## Conditions studied

- Enterobacterial Infection

## Interventions

- **DIAGNOSTIC_TEST:** Stool culture ans swab

## Key facts

- **NCT ID:** NCT03338738
- **Lead sponsor:** Fondation Hôpital Saint-Joseph
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-19
- **Primary completion:** 2021-03-31
- **Final completion:** 2021-05-28
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2021-06-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03338738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03338738, "Impact of Beta-lactams on the Microbiota and Relative Fecal Abundance of Mulltidrug Resistant Bacteria". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03338738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*